G-protein-coupled receptor kinase expression in hypertension

Citation
R. Gros et al., G-protein-coupled receptor kinase expression in hypertension, CLIN PHARM, 65(5), 1999, pp. 545-551
Citations number
25
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
CLINICAL PHARMACOLOGY & THERAPEUTICS
ISSN journal
00099236 → ACNP
Volume
65
Issue
5
Year of publication
1999
Pages
545 - 551
Database
ISI
SICI code
0009-9236(199905)65:5<545:GRKEIH>2.0.ZU;2-7
Abstract
In human hypertension we have recently identified an increase in lymphocyte G-protein receptor kinase-2 (GRK-2) protein expression, the key protein re gulating the interaction between G-protein-coupled receptors and activation of adenylyl cyclase, However, it was not known whether this increase in GR K-2 protein expression was attributable to regulation at the level of trans lation, furthermore, the relationship between extent of GRK-2 expression, r eceptor activation of adenylyl cyclase, and blood pressure was unclear. We therefore studied lymphocytes from 7 young subjects with borderline hyperte nsion and 14 young normotensive subjects, Immunodetectable GRK-2 protein ex pression in lymphocytes from subjects with hypertension was increased (155% +/- 7% of normotensive subjects; P < .05), In addition, GRK-2 protein expr ession was positively correlated with blood pressure (r = 0.53; P = .013) a nd inversely correlated with beta-adrenergic-mediated adenylyl cyclase acti vity (r = -0.54, P = .012), However, lymphocyte GRK-2 messenger ribonucleic acid (mRNA) content was not altered (110% +/- 13% of that observed in norm otensive control subjects). Increased GRK-2 protein expression may be an im portant factor in the impairment of beta-adrenergic-mediated vasodilation, characteristic of the hypertensive state.